2021
Prior Stroke and Age Predict Acute Ischemic Stroke Among Hospitalized COVID-19 Patients: A Derivation and Validation Study
Peng TJ, Jasne AS, Simonov M, Abdelhakim S, Kone G, Cheng YK, Rethana M, Tarasaria K, Herman AL, Baker AD, Yaghi S, Frontera JA, Sansing LH, Falcone GJ, Spudich S, Schindler J, Sheth KN, Sharma R. Prior Stroke and Age Predict Acute Ischemic Stroke Among Hospitalized COVID-19 Patients: A Derivation and Validation Study. Frontiers In Neurology 2021, 12: 741044. PMID: 34675873, PMCID: PMC8524436, DOI: 10.3389/fneur.2021.741044.Peer-Reviewed Original ResearchAcute ischemic strokeHospitalized COVID-19 patientsCOVID-19 patientsCOVID-19 cohortNeurologic symptomsPrior strokeIschemic strokeAIS patientsDerivation cohortControl cohortRisk of AISMultivariable logistic regression modelIschemic stroke riskCOVID-19 severityYale New Haven HealthLogistic regression modelsHospital presentationIndependent predictorsStroke riskMajor health systemsHigh riskPatientsYounger ageCohortStroke
2020
Vertebral Artery Stenosis
Brooks D, Schindler J. Vertebral Artery Stenosis. Current Treatment Options In Cardiovascular Medicine 2020, 22: 35. DOI: 10.1007/s11936-020-00832-y.Peer-Reviewed Original ResearchVertebral artery stenosisArtery stenosisEndovascular therapyAggressive risk factor controlExtracranial vertebral artery stenosisHigh-intensity statin therapyIntracranial vertebral artery stenosisSymptomatic vertebral artery stenosisDual antiplatelet therapyLipid-Lowering TherapyRisk factor controlLipid-lowering agentsRisk of strokeNovel lipid-lowering agentsAggressive initiationAntiplatelet therapyStatin therapyCommon conditionHigh riskStenosisMedical careTherapyNatural historyTherapy protocolsStroke
2014
Perioperative Stroke: Risk Assessment, Prevention and Treatment
Brooks DC, Schindler JL. Perioperative Stroke: Risk Assessment, Prevention and Treatment. Current Treatment Options In Cardiovascular Medicine 2014, 16: 282. PMID: 24420083, DOI: 10.1007/s11936-013-0282-1.Peer-Reviewed Original ResearchPostoperative atrial fibrillationPerioperative strokeAtrial fibrillationPerioperative periodTreatment optionsHigh riskAngiotensin-Converting Enzyme Inhibitor TherapyCoronary artery bypass graft surgeryConverting Enzyme Inhibitor TherapyModifiable risk factor reductionArtery bypass graft surgeryAortic atheromatous plaquesBypass graft surgeryRisk factor reductionNarrow therapeutic windowBeta blockadeCABG patientsEpiaortic ultrasoundAortic manipulationGraft surgeryBeta blockersCarotid revascularizationPerioperative managementPreoperative aspirinSurgical patients
2013
Tissue plasminogen activator via cross-collateralization for tandem internal carotid and middle cerebral artery occlusion.
Bulsara KR, Ediriwickrema A, Pepper J, Robertson F, Aruny J, Schindler J. Tissue plasminogen activator via cross-collateralization for tandem internal carotid and middle cerebral artery occlusion. World Journal Of Clinical Cases 2013, 1: 290-4. PMID: 24364024, PMCID: PMC3868713, DOI: 10.12998/wjcc.v1.i9.290.Peer-Reviewed Original ResearchTissue plasminogen activatorMiddle cerebral artery occlusionTandem internal carotidCerebral artery occlusionArtery occlusionInternal carotidIntra-arterial tissue plasminogen activatorPlasminogen activatorEndovascular carotid stentingFurther embolic eventsHealth Stroke ScaleSystemic thrombolysisCarotid dissectionStroke ScaleEmbolic eventsCarotid stentingPoor outcomeCurrent treatmentHigh riskFull recoveryNational InstituteCarotidDissectionOcclusionFurther support